Cell injection for Parkinson's disease
Part of Brain & nervous system clinical trials.
This early-stage trial tests a new treatment where specialized cells are injected directly into the brain. It is for people with advanced Parkinson's who have been on levodopa for a while and experience 'off' periods or involuntary movements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 39 and 75 years old.
- You have had Parkinson's disease for more than 5 years.
- You take levodopa but still have 'off' periods when symptoms return or you get involuntary movements (dyskinesia).
- You have at least 3 hours of 'off' time each day and are in Hoehn and Yahr stage 2.5 to 4 when off.
- Your symptoms improve by at least 30% when you take your Parkinson's medication.
- You have not had deep brain stimulation (DBS) surgery or other brain surgeries for Parkinson's.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for Parkinson's disease where special cells are injected directly into the brain. It aims to reduce 'off' time and improve movement control for people who have had Parkinson's for over 5 years and take levodopa but still experience daily complications.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.
This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.
This trial tests an injection called iDAP for people with Parkinson's disease. It aims to see if it can improve movement symptoms. You may be able to join if you are between 45 and 75 years old and have had Parkinson's for 4 to 20 years.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.